Subgroup | Having curative treatment vs no curative treatment | Having surgery vs other curative treatment | ||||
---|---|---|---|---|---|---|
Odds ratio | 95% CI | p-value | Odds ratio | 95% CI | p-value | |
Sex | ||||||
Female | Ref | Ref | ||||
Male | 0.85 | (0.51 - 1.41) | 0.536 | 1.26 | (0.70 - 2.29) | 0.446 |
Ethnicity | ||||||
Māori | 0.80 | (0.46 - 1.38) | 0.424 | 1.03 | (0.53 - 2.00) | 0.932 |
Non-Māori | Ref | Ref | ||||
Age (Continuous) | 0.92 | (0.89 - 0.95) | < 0.001 | 0.91 | (0.87 - 0.95) | < 0.001 |
Smoking status | ||||||
Current smoker | 0.40 | (0.12 - 1.38) | 0.149 | 0.11 | (0.02 - 0.46) | 0.003 |
Ex-smoker | 0.49 | (0.15 - 1.57) | 0.229 | 0.23 | (0.06 - 0.89) | 0.033 |
Never smoked | Ref | Ref | ||||
Charlson Comorbidity | ||||||
0 | Ref | Ref | ||||
1 | 0.82 | (0.36 - 1.87) | 0.644 | 0.43 | (0.17 - 1.11) | 0.080 |
2 | 1.06 | (0.45 - 2.50) | 0.902 | 0.35 | (0.13 - 0.93) | 0.035 |
3 | 0.93 | (0.34 - 2.54) | 0.894 | 0.20 | (0.06 - 0.73) | 0.015 |
4+ | 0.55 | (0.15 - 2.02) | 0.365 | 0.10 | (0.02 - 0.56) | 0.009 |
Year of diagnosis (Continuous) | 1.15 | (1.03 - 1.28) | 0.015 | 0.75 | (0.65 - 0.86) | < 0.001 |
Stage | ||||||
I | Ref | Ref | ||||
II | 0.29 | (0.17 - 0.48) | < 0.001 | 0.58 | (0.31 - 1.08) | 0.088 |
Cell type | ||||||
NSCLC | Ref | Ref | ||||
Others | 0.29 | (0.17 - 0.51) | < 0.001 | 0.08 | (0.03 - 0.23) | < 0.001 |
FEV1 | ||||||
< 50% | 0.35 | (0.16 - 0.77) | 0.009 | 0.04 | (0.01 - 0.12) | < 0.001 |
50%~ 80% | 0.70 | (0.36 -\ 1.38) | 0.304 | 0.42 | (0.20 - 0.85) | 0.016 |
80%+ | Ref | Ref | ||||
ECOG | ||||||
0 | Ref | Ref | ||||
1 | 0.52 | (0.26 - 1.02) | 0.056 | 0.57 | (0.30 - 1.09) | 0.091 |
2+ | 0.13 | (0.06 - 0.26) | < 0.001 | 0.14 | (0.05 - 0.40) | < 0.001 |